Jensen Peder

Director at Acorda Therapeutics, Inc. · on record since Apr 21, 2011
Director at BIOCRYST PHARMACEUTICALS INC · on record since May 16, 2011
Director at FIVE PRIME THERAPEUTICS, INC. · on record since Sep 17, 2013

Insider trading activity of Jensen Peder

Transactions on record: 46; since Apr 21, 2011

Open-market buys: 4; $156.9K

Open-market sells: 2; $1.1M

Companies traded: 3; last filing Jun 23, 2023

Figures computed from official regulatory filings — .

Companies where Jensen Peder has traded

Acorda Therapeutics, Inc.15 tx · Jun 23, 2023
FIVE PRIME THERAPEUTICS, INC.21 tx · $1.2M · Apr 19, 2021
BIOCRYST PHARMACEUTICALS INC10 tx · $156.9K · May 6, 2014

Track record of Jensen Peder

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Jensen Peder

Co-insiders of Jensen Peder

BIOTECHNOLOGY VALUE FUND II LPBIOCRYST PHARMACEUTICALS INC +1
BIOTECHNOLOGY VALUE FUND L PBIOCRYST PHARMACEUTICALS INC +1
BVF INC/ILBIOCRYST PHARMACEUTICALS INC +1
BVF PARTNERS L P/ILBIOCRYST PHARMACEUTICALS INC +1
Cohen Fred EBIOCRYST PHARMACEUTICALS INC +1
14159 capital (GP), LLCBIOCRYST PHARMACEUTICALS INC
14159, L.P.BIOCRYST PHARMACEUTICALS INC
667, L.P.BIOCRYST PHARMACEUTICALS INC
ABERCROMBIE GEORGE BBIOCRYST PHARMACEUTICALS INC
Adage Capital Advisors, L.L.C.FIVE PRIME THERAPEUTICS, INC.
ADAGE CAPITAL PARTNERS GP LLCFIVE PRIME THERAPEUTICS, INC.
ADAGE CAPITAL PARTNERS LPFIVE PRIME THERAPEUTICS, INC.
ALEXANDER W JAMESBIOCRYST PHARMACEUTICALS INC
ASELAGE STEVEBIOCRYST PHARMACEUTICALS INC
Atchinson RobertFIVE PRIME THERAPEUTICS, INC.
ATWOOD BRIAN GFIVE PRIME THERAPEUTICS, INC.
BAB BIO VENTURES LLPAcorda Therapeutics, Inc.
BAB BIO VENTURES NVAcorda Therapeutics, Inc.
Babu Yarlagadda SBIOCRYST PHARMACEUTICALS INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Acorda Therapeutics, Inc.Listing unverified	Jun 23, 2023	AwardD (derivative)	1,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 14, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 4, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 17, 2020	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 18, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 21, 2019	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jun 12, 2019	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Mar 12, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 29, 2018	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 14, 2018	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 2, 2017	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 12, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	ExerciseD (derivative)	4,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Exercise	4,065	5.54 USD	$22.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	ExerciseD (derivative)	4,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Exercise	4,065	7.26 USD	$29.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Sell	-8,130	55.30 USD	$449.6K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jul 28, 2016	Exercise	12,195	8.49 USD	$103.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jul 28, 2016	Sell	-12,195	49.50 USD	$603.7K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Acorda Therapeutics, Inc.Listing unverified	Jun 23, 2023	AwardD (derivative)	1,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 14, 2022	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 4, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-12,500	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Apr 19, 2021	OtherD (derivative)	-20,000	—	n/a (No price was disclosed in the filing)	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 17, 2020	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 18, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 21, 2019	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jun 12, 2019	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Mar 12, 2019	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 29, 2018	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 14, 2018	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acorda Therapeutics, Inc.Listing unverified	Jun 2, 2017	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	May 12, 2017	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	ExerciseD (derivative)	4,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Exercise	4,065	5.54 USD	$22.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	ExerciseD (derivative)	4,065	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Exercise	4,065	7.26 USD	$29.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Nov 10, 2016	Sell	-8,130	55.30 USD	$449.6K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jul 28, 2016	Exercise	12,195	8.49 USD	$103.5K	SEC
FIVE PRIME THERAPEUTICS, INC.Listing unverified	Jul 28, 2016	Sell	-12,195	49.50 USD	$603.7K	SEC